Press Area

Press release list of thematic 'Immunology, Inflammation, Infectiology and Microbiology'


Fecal incontinence : a novel therapy for a distressing condition

Fecal incontinence : a novel therapy for a distressing condition

May 30 2017

Inserm researchers in Rouen (Unit 1234 “PANTHER: Physiopathology, autoimmunity, neuromuscular diseases and regenerative therapies”, Inserm/Université de Rouen Normandie) have tested with success a cell therapy aiming to restore the ability of the...
Read more...

Men/Women: not all equal in the face of allergic asthma

Men/Women: not all equal in the face of allergic asthma

May 22 2017

Researchers led by Jean-Charles Guéry of the Centre for Pathophysiology Toulouse Purpan (Inserm/Université Toulouse III – Paul Sabatier/ CNRS) are providing new insights into the possible link between male hormones and differences in gender in sus...
Read more...

The composition of gut microbiota can predict the efficacy and tolerance of immunotherapy in people with cancer

The composition of gut microbiota can predict the efficacy and tolerance of immunotherapy in people with cancer

April 27 2017

Teams from AP-HP, INRA, Gustave Roussy and Inserm can demonstrate the role of microbiota in the response of immunotherapy for cancer. They show that in man, the composition of gut microbiota can help to identify the patients who will respond favou...
Read more...


Epstein-Barr virus and cancer: new tricks from an old dog

February 10 2017

Almost everybody has it: Scientists estimate that approximately 95 percent of adults around the world are infected with the Epstein-Barr virus. In rare cases, an infection with this virus causes cancer. Scientists at the German Cancer Research Cen...
Read more...


Ebola survivors: life afterwards

January 14 2017

The long-term clinical and social sequelae following survival of Ebola infection are unknown. In November 2014, i.e. less than a year after the start of the Ebola epidemic in West Africa, Inserm, in partnership with the French National Institute f...
Read more...
^ Top of page